AAF
MRNA icon

Andra AP-fonden’s Moderna MRNA Stock Holding History

Andra AP-fonden’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-600
Closed -$40.1K – 436
2024
Q3 		$40.1K Sell
600
-1,700
-74% -$156K ﹤0.01% 422
2024
Q2 		$273K Buy
+2,300
New +$291K ﹤0.01% 393
2024
Q1 		– Sell
-92,800
Closed -$9.23M – 411
2023
Q4 		$9.23M Buy
92,800
+33,800
+57% +$2.84M 0.49% 73
2023
Q3 		$6.09M Sell
59,000
-3,200
-5% -$357K 0.36% 128
2023
Q2 		$7.56M Buy
62,200
+13,400
+27% +$1.79M 0.19% 223
2023
Q1 		$7.49M Buy
48,800
+20,000
+69% +$3.3M 0.2% 225
2022
Q4 		$5.17M Sell
28,800
-6,800
-19% -$1.11M 0.16% 300
2022
Q3 		$4.21M Buy
35,600
+8,900
+33% +$1.35M 0.14% 330
2022
Q2 		$3.81M Buy
+26,700
New +$3.82M 0.11% 411
2021
Q4 		$6.86M Buy
27,000
+6,600
+32% +$1.93M 0.14% 346
2021
Q3 		$7.85M Buy
20,400
+600
+3% +$221K 0.16% 306
2021
Q2 		$4.65M Buy
+19,800
New +$3.54M 0.1% 457
2020
Q4 		– Sell
-21,700
Closed -$1.53M – 635
2020
Q3 		$1.53M Sell
21,700
-40,700
-65% -$2.84M 0.04% 580
2020
Q2 		$4.01M Buy
+62,400
New +$3.42M 0.12% 461

Other funds holding MRNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return

Andra AP-fonden's MRNA Position: Q4 2024 in Review

Andra AP-fonden sold out of Moderna (MRNA) in Q4 2024, closing a stake of 600 shares — an estimated $40.1K sold.

Andra AP-fonden first reported a position in MRNA in Q2 2020 and held it in 14 quarters. The position peaked at $9.23M in Q4 2023. 745 funds tracked by Wall St. Rank hold MRNA as of Q4 2024.

  • Andra AP-fonden reported no remaining Moderna position as of Q4 2024 after selling out during the quarter.
  • Andra AP-fonden sold 600 Moderna shares in Q4 2024, an estimated $40.1K.
  • Andra AP-fonden first reported a position in Moderna in Q2 2020 and held it in 14 quarters.
  • Andra AP-fonden's Moderna position peaked at $9.23M in Q4 2023.
  • 745 funds tracked by Wall St. Rank held Moderna as of Q4 2024.

Based on Andra AP-fonden's 13F filing for Q4 2024, filed 7 Feb 2025.